⌘K

Login Start Free

Home/Filings/4/0000899243-21-008077

4//SEC Filing

Shegog Todd 4

Accession 0000899243-21-008077

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 6:36 PM ET

Size

5.5 KB

Accession

0000899243-21-008077

Insider Transaction Report

Form 4

Period: 2021-02-22

Cogent Biosciences, Inc.COGT

Director

Transactions

Award
Stock Option (Right to Buy)
2021-02-22+37,500→ 37,500 total
Exercise: $8.59Exp: 2031-02-22→ Common Stock (37,500 underlying)

Footnotes (1)

[F1]This stock option shall vest in equal monthly installments over a three year period.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001714564

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 6:36 PM ET
Size: 5.5 KB

View on SEC.gov